![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
|
此舉將重塑公司的財政部儲備,同時繼續關注整個亞洲的醫療保健。
Basel Medical Group Ltd (Nasdaq: BMGL) is in the midst of a substantial financial transformation. As disclosed in a recent filing with the U.S. Securities and Exchange Commission (SEC), the company has entered into exclusive negotiations for a $1 billion acquisition of Bitcoin (BTC) from a private seller.
巴塞爾醫學集團有限公司(NASDAQ:BMGL)處於實質性的財務轉型之中。正如最近提交給美國證券交易委員會(SEC)的一份文件中所披露的那樣,該公司已通過從私人賣方從10億美元收購比特幣(BTC)進行獨家談判。
This deal, still subject to standard closing conditions and regulatory approvals, is being structured as a share-swap transaction with institutional investors and high-net-worth individuals from the cryptocurrency sector, who will be converting their BMGL shares into preferred shares.
這項協議仍然受到標準結束條件和監管部門的批准,正在與來自加密貨幣行業的機構投資者和高淨值個人的股票交易結構,他們將將其BMGL股份轉換為首選股票。
Upon completion, which is anticipated within the current financial quarter, the company will be incrementally funded with $1 billion in capital, positioning BMGL among the most financially flexible medical service providers in the Asia-Pacific region.
預計將在本財政季度內完成後,該公司將獲得10億美元的資本資金,將BMGL定位為亞太地區最靈活的醫療服務提供商。
The company's shares rose by 5.4% in premarket trading on Wednesday.
該公司的股票在周三的上市交易中增長了5.4%。
Basel Medical is currently seeking to expand its presence in emerging Asian healthcare markets, and this transaction is expected to diversify the company's balance sheet and provide it with greater access to capital for future acquisitions.
巴塞爾醫療公司目前正在尋求擴大其在新興的亞洲醫療保健市場中的影響力,預計該交易將使公司的資產負債表多樣化,並為其提供更多的資本供未來收購。
"This $1 billion financial transformation will give us the capacity to execute our Asia growth strategy while maintaining conservative financial management," said Dr. Darren Chhoa, Chief Executive Officer of BMGL.
BMGL首席執行官Darren Chhoa博士說:“這種10億美元的財務轉型將使我們能夠在維持保守的財務管理的同時執行亞洲增長戰略。”
"We are also cognizant of the importance of aligning our actions with our values. This move supports our mission to become a top-tier healthcare platform in the region, offering high-quality medical services with integrity and efficiency," he added.
他補充說:“我們還認識到使我們的行動與價值觀保持一致的重要性。此舉支持我們成為該地區頂級醫療平台的使命,提供具有正直和效率的高質量醫療服務。”
The company is working closely with a group of crypto-focused investors to finalize the terms of the transaction, which will be structured to ensure optimal tax treatment for all parties involved.
該公司正在與一群以加密貨幣為中心的投資者進行緊密合作,以最終確定交易條款,這些條款將是結構的,以確保所有有關方面的最佳稅收待遇。
The transaction is expected to close in the third quarter of 2023, subject to regulatory approvals, including those from the relevant authorities in Singapore and the United States, as well as other standard closing conditions.
預計該交易將在2023年第三季度完成,但要獲得法規批准,包括來自新加坡和美國的相關當局以及其他標準關閉條件的交易。
免責聲明:info@kdj.com
所提供的資訊並非交易建議。 kDJ.com對任何基於本文提供的資訊進行的投資不承擔任何責任。加密貨幣波動性較大,建議您充分研究後謹慎投資!
如果您認為本網站使用的內容侵犯了您的版權,請立即聯絡我們(info@kdj.com),我們將及時刪除。